Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates

Significant progress has been made in the advancement of RNAi therapeutics by combining a synthetic triantennary N-acetylgalactosamine ligand targeting the asialoglycoprotein receptor with chemically modified small interfering RNA (siRNA) designs, including the recently described Enhanced Stabilizat...

Descripción completa

Detalles Bibliográficos
Autores principales: Foster, Donald J., Brown, Christopher R., Shaikh, Sarfraz, Trapp, Casey, Schlegel, Mark K., Qian, Kun, Sehgal, Alfica, Rajeev, Kallanthottathil G., Jadhav, Vasant, Manoharan, Muthiah, Kuchimanchi, Satya, Maier, Martin A., Milstein, Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910670/
https://www.ncbi.nlm.nih.gov/pubmed/29456020
http://dx.doi.org/10.1016/j.ymthe.2017.12.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910670/
https://www.ncbi.nlm.nih.gov/pubmed/29456020
http://dx.doi.org/10.1016/j.ymthe.2017.12.021

Ejemplares similares